[Autologous blood stem cell transplantation].
Autologous blood stem cell transplantation (ABSCT) has been increasingly used, as the third generation of hemopoietic stem cell transplantation next to allogeneic and autologous bone marrow transplantation (allo-BMT and ABMT), in the treatment of malignant diseases. As to the principle of treatment, ABSCT is identical to ABSCT. However, ABSCT has some advantages over ABMT as follows: 1) a rapid engraftment, 2) no requirement of general anesthesia for harvesting hemopoietic stem cells, and 3) possibility of less contamination of tumor cells. Accordingly, ABSCT will take place of ABMT in the strategy of cancer treatment and improved results will be expected.
Harada
M
M
First Dept. of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
D000328:Adult; D016913:Blood Component Transfusion / Q000379:methods*; D001804:Blood Transfusion, Autologous / Q000379:methods; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000628:therapy; D033581:Stem Cell Transplantation